Danish Machinery Stock News

If you have been wondering whether Novo Nordisk is a bargain or a value trap at today’s price, you are not alone. This article is going to walk you through the key numbers that actually matter. The shares recently closed at 309.35, with a 3.4% gain over the last 7 days, a roughly flat -0.5% over 30 days, but a sharp slide of -51.6% year to date and -58.7% over the last year. This tells us the market’s view of its risk and growth potential has shifted dramatically, despite a still respectable...

Pandora (CPSE:PNDORA) is back in focus after the board accelerated its leadership transition, moving Berta de Pablos-Barbier into the CEO seat earlier than planned. This shift could subtly reshape the jewelry maker’s strategy. See our latest analysis for Pandora. The leadership shake up is landing against a tough backdrop, with a roughly 46 percent year to date share price return in negative territory and a 42 percent negative total shareholder return over 12 months. However, the three year...

Ringkjøbing Landbobank recently reported that, under its ongoing share buyback programme running until 30 January 2026, it has repurchased 612,277 shares for up to DKK 1,000 million, equivalent to 4.04% of its share capital. This progress update highlights a substantial capital allocation towards reducing the share count, which can meaningfully influence ownership concentration and per-share metrics. We’ll now explore how this sizeable DKK 1,000 million buyback commitment shapes Ringkjøbing...

Jyske Bank (CPSE:JYSK) has quietly delivered a strong run for shareholders, with the stock up about 7% over the past month and roughly 18% in the past 3 months. That outperformance raises a clear question: does the current price still make sense? See our latest analysis for Jyske Bank. Zooming out, that recent momentum sits on top of a powerful trend, with a year to date share price return above 60% and a five year total shareholder return near 300%. This suggests sentiment has steadily...

Wondering if Vestas Wind Systems is still worth buying after its huge run up, or if you have already missed the best of the upside? You are in the right place if you want a clear view on what the current price really implies. Vestas has quietly staged a big comeback, with the share price up 6.5% over the last week, 10.2% over the past month, and a striking 63.8% year to date, translating into an 80.1% gain over the last year despite still being down over 3 and 5 years. Part of this momentum...

Key Insights German High Street Properties' estimated fair value is kr.50.21 based on 2 Stage Free Cash Flow to Equity...

UIE (CPSE:UIE) just lined up a double move for shareholders, launching parallel Safe Harbour and Block trade buyback programs while also setting both special and regular cash dividends payable in mid December. See our latest analysis for UIE. The combination of hefty buybacks and twin dividends comes after a strong run, with a 90 day share price return of 31.87 percent and a three year total shareholder return of 153.80 percent, signaling momentum rather than a one off spike. If you like how...

Earlier this week, Danish engineering group FLSmidth was upgraded from "hold" to "buy" by ABG Sundal Collier, with the broker citing expectations of stronger financials, margin expansion and support from higher metal prices as the company exits a major restructuring phase under departing CEO Mikko Keto. The upgrade underscores how FLSmidth’s completed turnaround and exposure to improving metals markets are reshaping expectations for its order pipeline and profitability profile. We’ll now...

Demant A/S ( CPH:DEMANT ), might not be a large cap stock, but it saw significant share price movement during recent...

A number of NKT A/S ( CPH:NKT ) insiders sold their shares in the last year, which may have raised concerns among...

This week we saw the GN Store Nord A/S ( CPH:GN ) share price climb by 11%. But will that heal all the wounds inflicted...

Vestas Wind Systems (CPSE:VWS) has been busy, landing a string of European turbine orders from Germany to Poland and Italy, as well as a large undisclosed 660 MW EMEA deal that underlines sustained demand for its platforms. See our latest analysis for Vestas Wind Systems. These orders are landing against a strong backdrop, with the share price up 46.14 percent over the past 90 days and a hefty 63.51 percent year to date. The 1 year total shareholder return of 80.16 percent highlights how...

Aktieselskabet Schouw & Co. recently issued consolidated guidance for 2026, projecting 2025 revenue of roughly DKK 16,000 million to DKK 17,000 million and EBIT of DKK 1,100 million to DKK 1,200 million. This fresh earnings outlook gives investors a clearer read on the conglomerate’s profit expectations across its aquaculture feed, industrial and materials businesses. Next, we’ll explore how this updated DKK 1,100–1,200 million EBIT outlook interacts with Schouw’s existing investment...

GreenMobility A/S ( CPH:GREENM ) shares have continued their recent momentum with a 28% gain in the last month alone...

RIAS A/S' ( CPH:RIAS B ) dividend is being reduced from last year's payment covering the same period to DKK26.00 on the...

Celebrations may be in order for AL Sydbank A/S ( CPH:ALSYDB ) shareholders, with the analysts delivering a significant...

When close to half the companies in Denmark have price-to-earnings ratios (or "P/E's") above 15x, you may consider ISS...

Flügger group (CPSE:FLUG B) has just posted its H1 2026 numbers, with revenue of DKK2.3 billion over the last twelve months and net income of DKK58 million setting the tone for a period where profitability has stayed modest. The company has seen revenue move from DKK1.2 billion in H1 2024 to DKK1.24 billion in H1 2025 and DKK1.03 billion in H2 2025, while EPS swung from DKK22.8 to DKK33.9 before dipping into negative territory at DKK-14.25 in the latest half, leaving investors focused on how...

Earlier in 2025, ROCKWOOL A/S launched a share buy-back programme running from 7 February 2025 to 5 February 2026, authorising repurchases of up to €150 million and bringing its holding to 4,364,356 B shares, or 2.06% of total share capital. This sizeable, year-long repurchase plan highlights management’s commitment to returning capital to investors and adjusting the company’s share count over time. Now, we’ll examine how this sizeable buy-back programme interacts with Rockwool’s existing...

If you are wondering whether Genmab is still a smart buy after its big run or if most of the upside is already priced in, this breakdown will help you assess whether the current share price reflects its long term potential. The stock is up 31.6% year to date and 40.1% over the last year, despite only modest moves of 2.5% over 30 days and a slight 0.8% dip in the last week. This suggests sentiment has improved even though the longer 3 and 5 year returns are still negative. Recently, Genmab...

UIE Plc has commenced two parallel share repurchase programmes authorised at its May 2025 AGM, allowing buybacks of up to 5% of issued share capital overall and up to 2% via a Safe Harbour programme capped at DKK 245,000,000, alongside past declarations of both regular and special cash dividends of DKK 3.30 each with an ex-dividend date of 3 December 2025. Together, the capital return through dividends and the intention to cancel repurchased shares signal a clear focus on shrinking the...

On 5 February 2025, Pandora announced a new share buyback programme, appointing Danske Bank as sole lead manager for a tranche running until 30 January 2026, with the dual aim of reducing share capital and meeting obligations under company incentive schemes. This renewed focus on returning capital while supporting employee incentives adds a capital-allocation angle to Pandora's brand and margin-focused transformation story. We’ll now examine how Pandora’s decision to shrink its share capital...

Zealand Pharma (CPSE:ZEAL) just doubled down on its obesity and metabolic health ambitions by unveiling its Metabolic Frontier 2030 roadmap alongside a new multi program collaboration with OTR Therapeutics on next generation metabolic drugs. See our latest analysis for Zealand Pharma. Those moves land against a backdrop where the share price has climbed roughly 25% over the last three months but still sits well below earlier levels, and the three year total shareholder return above 150%...

FLSmidth (CPSE:FLS) climbed after ABG Sundal Collier lifted its rating to buy, highlighting expectations of healthier orders as metal prices rise and as the group moves beyond a restructuring phase. See our latest analysis for FLSmidth. The upgrade adds to a year where FLSmidth’s share price has delivered a solid year to date gain despite a softer 30 day share price return, while the three year total shareholder return nearly doubles investors’ money and signals that momentum is broadly...